Independent Medical Education
Recently, Bristol-Myers Squibb divested ownership of its Metabolic interests, and those interests were acquired by AstraZeneca. As a result, Bristol-Myers Squibb will no longer be accepting new Metabolic-related medical education grant applications. If you are interested in applying for a grant in this area, you may consider contacting the AstraZeneca Medical Education Grants Office.
Vision: Bristol-Myers Squibb is recognized worldwide as a leader in supporting innovative, high-quality medical education that closes gaps in healthcare performance, strengthens professional skills and improves patient health.
Mission: Independent Medical Education (IME) strategically supports medical education activities in Bristol-Myers Squibb disease areas of focus which serve to maintain, develop or increase the knowledge, skills and professional performance of a healthcare provider.